(SUZ) Suzano Papel e Celulose - Ratings and Ratios
Pulp, Paper, Board, Tissue, Biofuel
SUZ EPS (Earnings per Share)
SUZ Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 22.8% |
| Value at Risk 5%th | 34.4% |
| Reward | |
|---|---|
| Sharpe Ratio | -0.50 |
| Alpha Jensen | -14.22 |
| Character | |
|---|---|
| Hurst Exponent | 0.459 |
| Beta | 0.195 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.01% |
| Mean DD | 16.05% |
Description: SUZ Suzano Papel e Celulose October 30, 2025
Suzano S.A. (NYSE:SUZ) is a Brazil-based integrated pulp and paper company that operates two primary segments: Pulp, and Paper & Consumer Goods. Its product portfolio spans coated and uncoated printing and writing papers, paperboards, tissue, market and fluff pulps, as well as a growing suite of bio-based and biotechnology offerings such as lignin derivatives, nanocrystalline pulps, and cellulose-based fibers for textiles.
Key operational metrics show Suzano produced roughly 10.5 million tonnes of pulp in 2023, delivering an adjusted EBITDA margin near 30%-well above the global paper-pulp average of ~22%. The business is highly sensitive to hardwood pulp prices, which are driven by demand from China’s packaging sector and the broader shift toward sustainable fibers. Additionally, Suzano’s commitment to forest restoration (over 200,000 ha under stewardship) and its renewable-energy generation capacity provide a modest hedge against carbon-pricing risk and bolster its ESG profile, a factor increasingly priced into institutional valuations.
For a deeper quantitative assessment of Suzano’s valuation dynamics and scenario analysis, you might find ValueRay’s platform a useful tool to explore the company’s risk-adjusted upside.
SUZ Stock Overview
| Market Cap in USD | 11,214m |
| Sub-Industry | Paper Products |
| IPO / Inception | 1996-02-27 |
| Return 12m vs S&P 500 | -20.9% |
| Analyst Rating | 4.60 of 5 |
SUZ Dividends
| Dividend Yield | 3.67% |
| Yield on Cost 5y | 3.80% |
| Yield CAGR 5y | -25.40% |
| Payout Consistency | 64.7% |
| Payout Ratio | 44.9% |
SUZ Growth Ratios
| CAGR | -2.69% |
| CAGR/Max DD Calmar Ratio | -0.08 |
| CAGR/Mean DD Pain Ratio | -0.17 |
| Current Volume | 2956.9k |
| Average Volume | 1948.3k |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (6.56b TTM) > 0 and > 6% of Revenue (6% = 3.07b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 2.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 57.16% (prev 45.18%; Δ 11.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 19.00b > Net Income 6.56b (YES >=105%, WARN >=100%) |
| Net Debt (83.97b) to EBITDA (27.71b) ratio: 3.03 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.20 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.24b) change vs 12m ago -1.27% (target <= -2.0% for YES) |
| Gross Margin 34.44% (prev 42.60%; Δ -8.16pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.23% (prev 27.86%; Δ 4.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.77 (EBITDA TTM 27.71b / Interest Expense TTM 6.13b) >= 6 (WARN >= 3) |
Altman Z'' 2.82
| (A) 0.18 = (Total Current Assets 42.58b - Total Current Liabilities 13.32b) / Total Assets 164.42b |
| (B) 0.16 = Retained Earnings (Balance) 26.38b / Total Assets 164.42b |
| (C) 0.11 = EBIT TTM 16.97b / Avg Total Assets 158.81b |
| (D) 0.39 = Book Value of Equity 46.63b / Total Liabilities 119.16b |
| Total Rating: 2.82 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.35
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 4.00% = 2.00 |
| 3. FCF Margin 10.60% = 2.65 |
| 4. Debt/Equity 2.21 = 0.45 |
| 5. Debt/Ebitda 3.03 = -1.81 |
| 6. ROIC - WACC (= 5.05)% = 6.32 |
| 7. RoE 16.52% = 1.38 |
| 8. Rev. Trend 34.09% = 2.56 |
| 9. EPS Trend -33.88% = -1.69 |
What is the price of SUZ shares?
Over the past week, the price has changed by -0.88%, over one month by +1.47%, over three months by -10.20% and over the past year by -9.88%.
Is Suzano Papel e Celulose a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SUZ is around 8.57 USD . This means that SUZ is currently overvalued and has a potential downside of -4.57%.
Is SUZ a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SUZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 50.4% |
| Analysts Target Price | 13.5 | 50.4% |
| ValueRay Target Price | 9.1 | 1.3% |
SUZ Fundamental Data Overview November 11, 2025
P/E Trailing = 8.8218
P/E Forward = 7.776
P/S = 0.2191
P/B = 1.4365
Beta = 0.195
Revenue TTM = 51.18b BRL
EBIT TTM = 16.97b BRL
EBITDA TTM = 27.71b BRL
Long Term Debt = 90.93b BRL (from longTermDebt, last fiscal year)
Short Term Debt = 4.64b BRL (from shortTermDebt, last quarter)
Debt = 99.81b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 83.97b BRL (from netDebt column, last quarter)
Enterprise Value = 135.57b BRL (59.34b + Debt 99.81b - CCE 23.57b)
Interest Coverage Ratio = 2.77 (Ebit TTM 16.97b / Interest Expense TTM 6.13b)
FCF Yield = 4.00% (FCF TTM 5.43b / Enterprise Value 135.57b)
FCF Margin = 10.60% (FCF TTM 5.43b / Revenue TTM 51.18b)
Net Margin = 12.82% (Net Income TTM 6.56b / Revenue TTM 51.18b)
Gross Margin = 34.44% ((Revenue TTM 51.18b - Cost of Revenue TTM 33.55b) / Revenue TTM)
Gross Margin QoQ = 30.44% (prev 35.26%)
Tobins Q-Ratio = 0.82 (Enterprise Value 135.57b / Total Assets 164.42b)
Interest Expense / Debt = 1.83% (Interest Expense 1.82b / Debt 99.81b)
Taxrate = 35.08% (1.06b / 3.02b)
NOPAT = 11.02b (EBIT 16.97b * (1 - 35.08%))
Current Ratio = 3.20 (Total Current Assets 42.58b / Total Current Liabilities 13.32b)
Debt / Equity = 2.21 (Debt 99.81b / totalStockholderEquity, last quarter 45.12b)
Debt / EBITDA = 3.03 (Net Debt 83.97b / EBITDA 27.71b)
Debt / FCF = 15.47 (Net Debt 83.97b / FCF TTM 5.43b)
Total Stockholder Equity = 39.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.99% (Net Income 6.56b / Total Assets 164.42b)
RoE = 16.52% (Net Income TTM 6.56b / Total Stockholder Equity 39.73b)
RoCE = 12.99% (EBIT 16.97b / Capital Employed (Equity 39.73b + L.T.Debt 90.93b))
RoIC = 8.31% (NOPAT 11.02b / Invested Capital 132.64b)
WACC = 3.25% (E(59.34b)/V(159.15b) * Re(6.73%) + D(99.81b)/V(159.15b) * Rd(1.83%) * (1-Tc(0.35)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.85%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈3.47b ; Y1≈2.28b ; Y5≈1.04b
Fair Price DCF = 16.57 (DCF Value 20.48b / Shares Outstanding 1.24b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -33.88 | EPS CAGR: -2.43% | SUE: 2.82 | # QB: 2
Revenue Correlation: 34.09 | Revenue CAGR: -5.91% | SUE: 0.02 | # QB: 0
Additional Sources for SUZ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle